NCT03583060

Brief Summary

The proposed project is the first pilot test to examine interoceptive function as a mechanistic biomarker underlying Mindful Awareness in Body-oriented Therapy (MABT). MABT, an empirically-validated and manualized protocol is explicitly designed to teach interoceptive awareness skills for emotion regulation and is thus an ideal intervention approach in which to address this gap in research. This study uses a two group, randomized design to examine neural and physiological biomarkers in response to MABT. Twenty-four individuals reporting moderate stress will be recruited from the community and randomized to 8-week MABT intervention or the control condition. The study aims are to: 1) evaluate whether interoceptive training improves interoceptive function in the MABT vs control condition, and 2) explore whether changes in interoceptive function correlate with improved health outcomes. Analyses will include within and between-group ANOVA of brain activity with symptom change as a covariate. This is the first study to test whether a clinical intervention aimed specifically at cultivating interoceptive awareness effects change on interoceptive biomarkers. The results will support larger NIH proposals to more comprehensively validate neuro and behavioral biomarkers of interoceptive training to enhance mental health, particularly targeting depression and substance use disorder that have identified interoceptive dysfunction and poor emotion regulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 26, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 11, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
Last Updated

May 13, 2020

Status Verified

May 1, 2020

Enrollment Period

6 months

First QC Date

June 26, 2018

Last Update Submit

May 11, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • interoceptive function

    Functional magnetic resonance imaging (fMRI)

    10 weeks

Study Arms (2)

MABT

EXPERIMENTAL

Receive 8 weekly sessions of Mindful Awareness in Body-oriented Therapy (MABT).

Behavioral: Mindful Awareness in body-oriented therapy

Control

NO INTERVENTION

Interventions

teaches interoceptive awareness skills for self care

MABT

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult (over 18)
  • Perceived Stress Scale scores indicating moderate stress levels
  • naive to mindfulness-based approaches (no prior experience)
  • agrees to forgo (non-study) manual therapies (e.g., massage) and mind-body therapies (e.g., mindfulness meditation) for 3 months (baseline to post-test)
  • fluent in English
  • can attend MABT and assessment sessions
  • right-handed (for uniformity of neuroimaging results)

You may not qualify if:

  • lifetime diagnosis of mental health disorder
  • unable to complete study participation (includes planned relocation, pending inpatient treatment, planned extensive surgical procedures, etc.)
  • cognitive impairment, assessed by the Mini-Mental Status Exam (MMSE) if demonstrated difficulty comprehending the consent
  • use of medications in the past 30 days that affect hemodynamic response
  • lifetime head injuries or loss of consciousness longer than 5 min
  • currently pregnant
  • contraindications for MRI, e.g., claustrophobia, metal objects in body, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington

Seattle, Washington, 98195, United States

Location

Study Officials

  • Cynthia Price, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR
  • Norman Farb, PhD

    University of Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assoc. Professor

Study Record Dates

First Submitted

June 26, 2018

First Posted

July 11, 2018

Study Start

May 1, 2018

Primary Completion

November 1, 2018

Study Completion

November 1, 2018

Last Updated

May 13, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations